新生學校財團法人新生醫護管理專科學校圖書館 |

Ex vivo cell therapy

紀錄類型:	書目-電子資源 : 單行本
正題名/作者:	Ex vivo cell therapy/ edited Klaus Schindhelm, Robert Nordon.
其他作者:	Schindhelm, Klaus.
出版者:	San Diego :Academic Press, : c1999.,
面頁冊數:	1 online resource (xix, 356 p.) :ill. :
標題:	Cellular therapy. -
電子資源:	http://www.sciencedirect.com/science/book/9780126249606
ISBN:	9780126249606

Ex vivo cell therapy
Ex vivo cell therapy[electronic resource] /edited Klaus Schindhelm, Robert Nordon. - San Diego :Academic Press,c1999. - 1 online resource (xix, 356 p.) :ill.

Includes bibliographical references and index.

R.E. Nordon and K. Schindhelm, Introduction. -- L. Robb, A.G. Elefanty, and C.G. Begley, Transcriptional Control of Hematopoieses. -- R. Starr and N.A. Nicola, Cell Signaling by Hemopoietic Growth Factor Receptors. -- P.J. Simmons, D.N. Haylock, and J.-P. Lâevesque, Influence of Cytokines and Adhesion Molecules on Hematopoietic Stem Cell Development. -- P.A. Rowlings, Allogeneic Hematopoietic Stem Cell Transplantation. -- U. Hahn and L.B. To, Autologous Stem Cell Transplantation. -- M.R. Vowels, Cord Blood Stem Cell Transplantation. -- S.R. Riddell, E.H. Warren, D. Lewinsohn, C. Yee, and P.D. Greenberg, Reconstitution of Immunity by Adoptive Immunotherapy with T Cells. -- L.Q. Sun, M. Miller, and G. Symonds, Exogenous Gene Transfer into Lymphoid and Hematopoietic Progenitor Cells. -- C. Dowding, T. Leemhuis, A. Jakubowski, and C. Reading, Process Development for Ex Vivo Cell Therapy. -- R.E. Nordon and K. Schindhelm, Cell Separation. -- P.W. Zandstra, C.J. Eaves, and J.M. Piret, Environmental Requirements of Hematopoietic Progenitor Cells in Ex Vivo Expansion Systems. -- R. Mandalam, M. Koller, and A. Smith, Ex Vivo Hematopoietic Cell Expansion for Bone Marrow Transplantation. -- M. Raponi and G. Symonds, Gene Delivery Technology: Nonviral and Viral Vector Systems. -- R.E. Nordon and K. Schindhelm, Summary and Future Directions. -- Index.

Over the last two decades advances in the understanding of disease at a cellular and molecular level has led to innovative therapies that are based on the administration of cells which have been modified outside of the body. Ex vivo cell therapy is in essence gene therapy delivered by transfer of therapeutic genes to cells in culture, which are then given to the patient to treat fatal infections such as AIDS, or other conditions such as cancer or genetic diseases. These manipulations include the purification and culture of therapeutic cell subtypes, as well as elimination of cells which cause disease (cancer cells or immune cells reacting to the body itself). Gene therapy can be delivered by transfer of therapeutic genes to cells in culture, which are then given to the patient to treat fatal infections such as AIDS, cancer or genetic diseases. For small-scale laboratory methods to become clinically applicable processes, these new therapies require efficient technologies for cell separation, cell production in culture and gene transfer. This book integrates the recent advances in biological and clinical research with developments in cell-based technologies to provide a comprehensive review for clinicians, researchers, biotechnologists and biomedical engineers working in this rapidly developing area. The biotechnology and pharmaceutical industry requires a broad perspective for development of future technologies, and this text will provide then with an excellent overview of this rapidly evolving field. Key Features * Comprehensive review by leading researchers * Hematopoietic stem cell development: transcriptional control, signaling pathways, hematopoietic growth factors and adhesion molecules * Clinical developments: hematopoietic stem cell transplantation, cellular immunotherapy and gene therapy * Enabling technologies: cell separation, bioreactors, and gene transfer regulatory issues.

ISBN: 9780126249606

Source: 84722:84722Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

126382
Cellular therapy.
Index Terms--Genre/Form:

96803
Electronic books.

LC Class. No.: RM287 / .E9 1999eb

Dewey Class. No.: 615.5

National Library of Medicine Call No.: 2000 C-076

Ex vivo cell therapy
LDR:05493cmm a2200361Ia 4500 001 139290
005 20120813080046.0
006 m d
007 cr cn|||||||||
008 160121s1999 caua ob 001 0 eng d
019 $a 649845788 $a 779916460
020 $a 9780126249606
020 $a 0126249601
029 1 $a NZ1 $b 12432532
029 1 $a CHVBK $b 13531111X
029 1 $a AU@ $b 000048129755
035 $a ocn162129210
037 $a 84722:84722 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $b eng $c OPELS $d OCLCQ $d OCLCE $d OCLCO
049 $a NTYA
050 4 $a RM287 $b .E9 1999eb
060 4 $a 2000 C-076
060 4 $a WH 380 $b E96 1999
082 0 4 $a 615.5 $2 22
245 0 0 $a Ex vivo cell therapy $h [electronic resource] / $c edited Klaus Schindhelm, Robert Nordon.
260 $a San Diego : $c c1999. $b Academic Press,
300 $a 1 online resource (xix, 356 p.) : $b ill.
504 $a Includes bibliographical references and index.
505 0 $a R.E. Nordon and K. Schindhelm, Introduction. -- L. Robb, A.G. Elefanty, and C.G. Begley, Transcriptional Control of Hematopoieses. -- R. Starr and N.A. Nicola, Cell Signaling by Hemopoietic Growth Factor Receptors. -- P.J. Simmons, D.N. Haylock, and J.-P. Lâevesque, Influence of Cytokines and Adhesion Molecules on Hematopoietic Stem Cell Development. -- P.A. Rowlings, Allogeneic Hematopoietic Stem Cell Transplantation. -- U. Hahn and L.B. To, Autologous Stem Cell Transplantation. -- M.R. Vowels, Cord Blood Stem Cell Transplantation. -- S.R. Riddell, E.H. Warren, D. Lewinsohn, C. Yee, and P.D. Greenberg, Reconstitution of Immunity by Adoptive Immunotherapy with T Cells. -- L.Q. Sun, M. Miller, and G. Symonds, Exogenous Gene Transfer into Lymphoid and Hematopoietic Progenitor Cells. -- C. Dowding, T. Leemhuis, A. Jakubowski, and C. Reading, Process Development for Ex Vivo Cell Therapy. -- R.E. Nordon and K. Schindhelm, Cell Separation. -- P.W. Zandstra, C.J. Eaves, and J.M. Piret, Environmental Requirements of Hematopoietic Progenitor Cells in Ex Vivo Expansion Systems. -- R. Mandalam, M. Koller, and A. Smith, Ex Vivo Hematopoietic Cell Expansion for Bone Marrow Transplantation. -- M. Raponi and G. Symonds, Gene Delivery Technology: Nonviral and Viral Vector Systems. -- R.E. Nordon and K. Schindhelm, Summary and Future Directions. -- Index.
505 0 $a Sec. 1. Introduction -- Sec. 2. Transcriptional control of hematopoiesis -- Sec. 3. Cell signaling by hematopoietic growth factor receptors -- Sec. 4. Influence of cytokines and adhesion molecules on hematopoietic stem cell development -- Sec. 5. Allogeneic hematopoietic stem cell transplantation -- Sec. 6. Autologous stem cell transplantation -- Sec. 7. Cord blood stem cell transplantation -- Sec. 8. Reconstitution of immunity by adoptive immunotherapy with T cells -- Sec. 9. Exogenous gene transfer into lymphoid and hematopoietic progenitor cells -- Sec. 10. Process development for ex vivo cell therapy -- Sec. 11. Cell separation -- Sec. 12. Environmental requirements of hematopoietic progenitor cells in ex vivo expansion systems -- Sec. 13. Ex vivo hematopoietic cell expansion for bone marrow transplantation -- Sec. 14. Gene delivery technology: nonviral and viral vector systems -- Sec. 15. Summary and future directions.
520 $a Over the last two decades advances in the understanding of disease at a cellular and molecular level has led to innovative therapies that are based on the administration of cells which have been modified outside of the body. Ex vivo cell therapy is in essence gene therapy delivered by transfer of therapeutic genes to cells in culture, which are then given to the patient to treat fatal infections such as AIDS, or other conditions such as cancer or genetic diseases. These manipulations include the purification and culture of therapeutic cell subtypes, as well as elimination of cells which cause disease (cancer cells or immune cells reacting to the body itself). Gene therapy can be delivered by transfer of therapeutic genes to cells in culture, which are then given to the patient to treat fatal infections such as AIDS, cancer or genetic diseases. For small-scale laboratory methods to become clinically applicable processes, these new therapies require efficient technologies for cell separation, cell production in culture and gene transfer. This book integrates the recent advances in biological and clinical research with developments in cell-based technologies to provide a comprehensive review for clinicians, researchers, biotechnologists and biomedical engineers working in this rapidly developing area. The biotechnology and pharmaceutical industry requires a broad perspective for development of future technologies, and this text will provide then with an excellent overview of this rapidly evolving field. Key Features * Comprehensive review by leading researchers * Hematopoietic stem cell development: transcriptional control, signaling pathways, hematopoietic growth factors and adhesion molecules * Clinical developments: hematopoietic stem cell transplantation, cellular immunotherapy and gene therapy * Enabling technologies: cell separation, bioreactors, and gene transfer regulatory issues.
588 $a Description based on print version record.
650 0 $a Cellular therapy. $3 126382
650 0 $a Hematopoietic stem cells $x Transplantation. $3 241606
650 1 2 $a Hematopoietic Stem Cell Transplantation. $3 72466
650 4 $a Gene therapy. $3 126963
650 4 $a Immunotherapy. $3 72173
650 7 $a Histotherapie. $2 fmesh $3 255457
650 7 $a Therapie genique. $2 fmesh $3 255458
650 7 $a Greffe de cellules souches hematopoietiques. $2 fmesh $3 255459
655 4 $a Electronic books. $2 local. $3 96803
700 1 $a Schindhelm, Klaus. $3 255455
700 1 $a Nordon, Robert. $3 255456
776 0 8 $i Print version: $t Ex vivo cell therapy. $d San Diego : Academic Press, c1999 $z 0126249601 $z 9780126249606 $w (DLC) 98089643 $w (OCoLC)42398064
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780126249606